185 related articles for article (PubMed ID: 36097103)
1. Astrocyte Responses to Complement Peptide C3a are Highly Context-Dependent.
Pekna M; Siqin S; de Pablo Y; Stokowska A; Torinsson Naluai Å; Pekny M
Neurochem Res; 2023 Apr; 48(4):1233-1241. PubMed ID: 36097103
[TBL] [Abstract][Full Text] [Related]
2. Complement Peptide C3a Promotes Astrocyte Survival in Response to Ischemic Stress.
Shinjyo N; de Pablo Y; Pekny M; Pekna M
Mol Neurobiol; 2016 Jul; 53(5):3076-3087. PubMed ID: 25972241
[TBL] [Abstract][Full Text] [Related]
3. Complement C3a activates astrocytes to promote medulloblastoma progression through TNF-α.
Gong B; Guo D; Zheng C; Ma Z; Zhang J; Qu Y; Li X; Li G; Zhang L; Wang Y
J Neuroinflammation; 2022 Jun; 19(1):159. PubMed ID: 35725556
[TBL] [Abstract][Full Text] [Related]
4. Expression of a functional anaphylatoxin C3a receptor by astrocytes.
Ischenko A; Sayah S; Patte C; Andreev S; Gasque P; Schouft MT; Vaudry H; Fontaine M
J Neurochem; 1998 Dec; 71(6):2487-96. PubMed ID: 9832147
[TBL] [Abstract][Full Text] [Related]
5. Astrocyte activation and reactive gliosis-A new target in stroke?
Pekny M; Wilhelmsson U; Tatlisumak T; Pekna M
Neurosci Lett; 2019 Jan; 689():45-55. PubMed ID: 30025833
[TBL] [Abstract][Full Text] [Related]
6. Complement C3a treatment accelerates recovery after stroke via modulation of astrocyte reactivity and cortical connectivity.
Stokowska A; Aswendt M; Zucha D; Lohmann S; Wieters F; Morán Suarez J; Atkins AL; Li Y; Miteva M; Lewin J; Wiedermann D; Diedenhofen M; Torinsson Naluai Å; Abaffy P; Valihrach L; Kubista M; Hoehn M; Pekny M; Pekna M
J Clin Invest; 2023 May; 133(10):. PubMed ID: 36995772
[TBL] [Abstract][Full Text] [Related]
7. Complement component C3a plays a critical role in endothelial activation and leukocyte recruitment into the brain.
Wu F; Zou Q; Ding X; Shi D; Zhu X; Hu W; Liu L; Zhou H
J Neuroinflammation; 2016 Jan; 13():23. PubMed ID: 26822321
[TBL] [Abstract][Full Text] [Related]
8. Complement activation contributes to perioperative neurocognitive disorders in mice.
Xiong C; Liu J; Lin D; Zhang J; Terrando N; Wu A
J Neuroinflammation; 2018 Sep; 15(1):254. PubMed ID: 30180861
[TBL] [Abstract][Full Text] [Related]
9. Receptor for complement peptide C3a: a therapeutic target for neonatal hypoxic-ischemic brain injury.
Järlestedt K; Rousset CI; Ståhlberg A; Sourkova H; Atkins AL; Thornton C; Barnum SR; Wetsel RA; Dragunow M; Pekny M; Mallard C; Hagberg H; Pekna M
FASEB J; 2013 Sep; 27(9):3797-804. PubMed ID: 23737250
[TBL] [Abstract][Full Text] [Related]
10. C3a expressed in the central nervous system protects against LPS-induced shock.
Boos L; Szalai AJ; Barnum SR
Neurosci Lett; 2005 Oct; 387(2):68-71. PubMed ID: 16085360
[TBL] [Abstract][Full Text] [Related]
11. Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activity.
Hung CC; Lee YH; Kuo YM; Hsu PC; Tsay HJ; Hsu YT; Lee CC; Liang JJ; Shie FS
J Neuroinflammation; 2019 Jun; 16(1):123. PubMed ID: 31176371
[TBL] [Abstract][Full Text] [Related]
12. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis.
Gasque P; Singhrao SK; Neal JW; Wang P; Sayah S; Fontaine M; Morgan BP
J Immunol; 1998 Apr; 160(7):3543-54. PubMed ID: 9531317
[TBL] [Abstract][Full Text] [Related]
13. Astrocyte-Derived Estrogen Regulates Reactive Astrogliosis and is Neuroprotective following Ischemic Brain Injury.
Wang J; Sareddy GR; Lu Y; Pratap UP; Tang F; Greene KM; Meyre PL; Tekmal RR; Vadlamudi RK; Brann DW
J Neurosci; 2020 Dec; 40(50):9751-9771. PubMed ID: 33158962
[TBL] [Abstract][Full Text] [Related]
14. Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death.
van Beek J; Nicole O; Ali C; Ischenko A; MacKenzie ET; Buisson A; Fontaine M
Neuroreport; 2001 Feb; 12(2):289-93. PubMed ID: 11209937
[TBL] [Abstract][Full Text] [Related]
15. Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging.
Propson NE; Roy ER; Litvinchuk A; Köhl J; Zheng H
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 32990682
[TBL] [Abstract][Full Text] [Related]
16. Astrocyte subtype-specific approach to Alzheimer's disease treatment.
Sarkar S; Biswas SC
Neurochem Int; 2021 May; 145():104956. PubMed ID: 33503465
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells decrease C3-positive reactive astrocytes in Alzheimer-like pathology.
Stym-Popper G; Matta K; Chaigneau T; Rupra R; Demetriou A; Fouquet S; Dansokho C; Toly-Ndour C; Dorothée G
J Neuroinflammation; 2023 Mar; 20(1):64. PubMed ID: 36890536
[TBL] [Abstract][Full Text] [Related]
18. A complement-microglial axis driving inhibitory synapse related protein loss might contribute to systemic inflammation-induced cognitive impairment.
Li SM; Li B; Zhang L; Zhang GF; Sun J; Ji MH; Yang JJ
Int Immunopharmacol; 2020 Oct; 87():106814. PubMed ID: 32707491
[TBL] [Abstract][Full Text] [Related]
19. Two different transduction pathways are activated by C3a and C5a anaphylatoxins on astrocytes.
Sayah S; Jauneau AC; Patte C; Tonon MC; Vaudry H; Fontaine M
Brain Res Mol Brain Res; 2003 Apr; 112(1-2):53-60. PubMed ID: 12670702
[TBL] [Abstract][Full Text] [Related]
20. Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury.
Wang Y; Li Y; Dalle Lucca SL; Simovic M; Tsokos GC; Dalle Lucca JJ
J Neuroinflammation; 2010 Apr; 7():24. PubMed ID: 20380727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
